LOADING
Comparing Merck & Company (MRK) and Netflix Inc (NFLX) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | NFLX |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $376.4B | $331.4B |
| P/E Ratio | 122.0 | 25.0 |
| Forward P/E | 55.6 | 25.3 |
| PEG Ratio | 10.47 | 1.78 |
| EPS | $1.25 | $3.18 |
| Revenue Growth (YoY) | 5.1% | 13.4% |
| Profit Margin | 4.8% | 28.2% |
| Return on Equity | 7.0% | 49.5% |
| Dividend Yield | 2.23% | -- |
| Beta | 0.21 | 1.51 |
| 52-Week High | $154.49 | $126.71 |
| 52-Week Low | $75.81 | $65.08 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Netflix Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Netflix Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.